BioXcel Therapeutics Announces Journal of the American Medical Association Publication of Data from SERENITY II Pivotal Phase 3 Trial Evaluating BXCL501 in Bipolar Disorders
BXCL501 demonstrated statistically significant and clinically meaningful improvements in primary and key secondary efficacy measures…
Airwheel Announces Expanded Global Deployment of AI-Enabled Rideable Smart Electric Cabin Suitcase
Casa Minerals Inc Announces Closing of Oversubscribed Private Placement, and Retains European Marketing Firm for Investor Awareness Services
GTJAI Sponsored Axera’s Listing on the Main Board of HKEX
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
Focus Graphite Engages Dr. Reuter Investor Relations to Expand German and European Capital Markets Presence